Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
暂无分享,去创建一个
J. Ward | Jeffrey L. Jones | D. Alderton | P. Fleming | J. Kaplan | D. Hanson | J. Jones | M. Dworkin | J. W. Ward
[1] P. Kissinger,et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. , 1998, The New England journal of medicine.
[2] J. Ward,et al. Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991-1996. , 1998, The Journal of infectious diseases.
[3] M. Feinberg,et al. Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. Vol. 47/No. RR-5. , 1998 .
[4] C. Beard,et al. Opportunistic Infections (OIs) as Emerging Infectious Diseases: Challenges Posed by OIs in the 1990s and Beyond , 1998 .
[5] J. Ward,et al. Estimating the number of AIDS-defining opportunistic illness diagnoses from data collected under the 1993 AIDS surveillance definition. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[6] G. Lemp,et al. Prevention of Pneumocystis carinii pneumonia: who are we missing? , 1997, AIDS.
[7] J. Ward,et al. Toxoplasmic encephalitis in HIV-infected persons: risk factors and trends , 1996, AIDS.
[8] J. Ward,et al. Tuberculosis among AIDS patients in the United States, 1993. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[9] R. Chaisson,et al. Natural History of Opportunistic Disease in an HIV-Infected Urban Clinical Cohort , 1996, Annals of Internal Medicine.
[10] David R. Holtgrave,et al. USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: A Summary , 1996, Annals of Internal Medicine.
[11] K. Holmes,et al. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] S. Spector,et al. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. , 1995, The New England journal of medicine.
[13] J. Phair,et al. Incidence of clinical AIDS conditions in a cohort of homosexual men with CD4+ cell counts < 100/mm3. Multicenter AIDS Cohort Study. , 1994, The Journal of infectious diseases.
[14] J. Ward,et al. Surveillance of AIDS‐defining conditions in the United States , 1994, AIDS.
[15] S. Buchbinder,et al. Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. , 1994, The Journal of infectious diseases.
[16] É. Oksenhendler,et al. Toxoplasma gondii infection in advanced HIV infection , 1994, AIDS.
[17] R. Chaisson,et al. Racial differences in the use of drug therapy for HIV disease in an urban community. , 1994, The New England journal of medicine.
[18] J P Matts,et al. Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS. , 1994, The Journal of infectious diseases.
[19] K. Castro,et al. Gender differences in reported AIDS-indicative diagnoses. , 1993, The Journal of infectious diseases.
[20] J. Ward,et al. Epidemiology of extrapulmonary tuberculosis among persons with AIDS in the United States. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] J. Phair,et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991. , 1993, American journal of epidemiology.
[22] C. Reed,et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. , 1992, JAMA.
[23] D. Vlahov,et al. Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV). , 1991, The Journal of infectious diseases.
[24] M. Chiasson,et al. Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). , 1991, AIDS.
[25] P. Selwyn,et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. , 1989, The New England journal of medicine.
[26] K. Mayer,et al. Natural history of acquired immunodeficiency syndrome in women in Rhode Island. , 1989, The American journal of medicine.
[27] Owen Devine,et al. Predicting AIDS incidence by extrapolating from recent trends , 1989 .
[28] Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. , 1989, MMWR supplements.
[29] R. Selik,et al. Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends. , 1987, AIDS.
[30] R. Redfield,et al. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. , 1987, JAMA.